The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERATE DIAGNOSTICS INC | COM | 00430H102 | 1,537 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 2,774 | 165,700 | SH | SOLE | 165,700 | 0 | 0 | ||
| AFFIMED N V | COM | N01045108 | 3,642 | 590,300 | SH | SOLE | 590,300 | 0 | 0 | ||
| AGILE THERAPEUTICS INC | COM | 00847L100 | 2,595 | 385,000 | SH | SOLE | 385,000 | 0 | 0 | ||
| ALDER PHARMACEUTICALS INC | COM | 014339105 | 527 | 16,100 | SH | SOLE | 16,100 | 0 | 0 | ||
| AMAG PHARMACEUTICALS INC | COM | 00163U106 | 7,946 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 3,397 | 1,760,000 | SH | SOLE | 1,760,000 | 0 | 0 | ||
| ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 7,650 | 1,310,000 | SH | SOLE | 1,310,000 | 0 | 0 | ||
| AURIS MED HLDG AG | COM | H03579101 | 1,264 | 355,000 | SH | SOLE | 355,000 | 0 | 0 | ||
| AVINGER INC | COM | 053734109 | 2,574 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 8,734 | 2,120,000 | SH | SOLE | 2,120,000 | 0 | 0 | ||
| BIOLINERX LTD | SPONSORED ADR | 09071M106 | 383 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | RIGHTS | 09627Y109 | 2,774 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| CARA THERAPEUTICS INC | COM | 140755109 | 5,930 | 415,000 | SH | SOLE | 415,000 | 0 | 0 | ||
| CELGENE CORP | RIGHTS 12/31/2030 | 151020112 | 547 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
| CEMPRA INC | COM | 15130J109 | 10,022 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 11,842 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 5,492 | 1,620,000 | SH | SOLE | 1,620,000 | 0 | 0 | ||
| CYNAPSUS THERAPEUTICS INC | COM | 23257Y859 | 469 | 29,000 | SH | SOLE | 29,000 | 0 | 0 | ||
| CYTRX CORP | COM PAR $.001 | 838828509 | 3,614 | 1,525,000 | SH | SOLE | 1,525,000 | 0 | 0 | ||
| EAGLE PHARMACEUTICALS INC | COM | 269796108 | 5,419 | 73,200 | SH | SOLE | 73,200 | 0 | 0 | ||
| EVOKE PHARMA INC | COM | 30049G104 | 757 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 7,124 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| FLAMEL TECHNOLOGIES SA | SPONSORED ADR | 338488109 | 5,056 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 2,089 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 5,037 | 1,825,000 | SH | SOLE | 1,825,000 | 0 | 0 | ||
| IMPRIMIS PHARMACEUTICALS INC | COM NEW | 45323A201 | 7,736 | 1,205,000 | SH | SOLE | 1,205,000 | 0 | 0 | ||
| INNOCOLL AG | SPONSORED ADR | 45780Q103 | 695 | 55,543 | SH | SOLE | 55,543 | 0 | 0 | ||
| INOTEK PHARMACEUTICALS CORP | COM | 45780VAA0 | 6,042 | 642,800 | SH | SOLE | 642,800 | 0 | 0 | ||
| INTEC PHARMA LTD JERUSALEM | SHS | M53644106 | 3,528 | 630,000 | SH | SOLE | 630,000 | 0 | 0 | ||
| MEDGENICS INC | COM NEW | 58436Q203 | 8,277 | 1,058,400 | SH | SOLE | 1,058,400 | 0 | 0 | ||
| MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 2,626 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 4,973 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| NIVALIS THERAPEUTICS INC | COM | 65481J109 | 2,272 | 175,200 | SH | SOLE | 175,200 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 4,255 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
| PROTALIX BIOTHERAPEUTICS INC | COM | 74365AAB7 | 4,295 | 3,640,000 | SH | SOLE | 3,640,000 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 7,496 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 846 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 6,454 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | ||
| TENAX THERAPEUTICS INC | COM | 88032L100 | 1,905 | 635,000 | SH | SOLE | 635,000 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 2,621 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
| TONIX PHARMACEUTICALS HLDG C | COM NEW | 890260201 | 3,015 | 570,000 | SH | SOLE | 570,000 | 0 | 0 | ||
| TRACON PHARMACEUTICALS INC | COM | 89237H10A | 119 | 12,172 | SH | SOLE | 12,172 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 3,196 | 245,275 | SH | SOLE | 245,275 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 10,594 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
| XOMA CORP DEL | COM | 98419J107 | 2,218 | 2,950,000 | SH | SOLE | 2,950,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,250 | 151,300 | SH | SOLE | 151,300 | 0 | 0 | ||
| ZOGENIX INC | COM | 98978L105 | 3,375 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| ZS PHARMA INC | COM | 98979G105 | 6,238 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||